首页> 外文期刊>Modern Pathology >Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
【24h】

Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions

机译:细胞周期抑制剂p27Kip1及其灭活剂Jab1在黑素细胞病变中的表达

获取原文
           

摘要

Decreased expression of p27 (a cyclin-dependent kinase inhibitor) is an adverse prognostic marker in a diverse array of human cancers. The purpose of this study was to investigate the expression of p27 and Jab1 (a protein involved in p27 degradation) in melanocytic lesions, and to identify their possible participation in melanoma progression. A tissue microarray was constructed using formalin-fixed, paraffin-embedded archival tissue blocks of 94 melanocytic lesions including 19 benign nevi, 21 dysplastic nevi, 23 melanomas, and 31 metastatic melanomas. The expression of p27 and Jab1 was evaluated by immunohistochemistry. The association between p27, Jab1, and clinicopathological parameters was analyzed using 2 and Fisher's exact tests. Nonparametric Pearson's rank correlation was applied to evaluate the relationship between p27 and Jab1 expression. p27 was expressed in 15 (88%) nevi, 18 (95%) dysplastic nevi, 11 (50%) melanomas, and only in four (13%) of the metastatic melanomas (PPr=-0.166). The low levels of p27 in primary and metastatic melanoma cases may explain the high proliferation rate of such lesions. Also, the relative high expression of Jab1 in metastatic melanoma, associated with low levels of p27, suggests that Jab1 may be involved in survival and proliferation of metastatic melanoma cells.
机译:p27(一种细胞周期蛋白依赖性激酶抑制剂)的表达降低是多种人类癌症中不良的预后标志物。这项研究的目的是调查黑素细胞病变中p27和Jab1(一种参与p27降解的蛋白质)的表达,并确定它们可能参与黑素瘤的进展。使用福尔马林固定,石蜡包埋的档案组织块对94个黑素细胞病变进行构建,该组织块包括19个良性痣,21个增生性痣,23个黑色素瘤和31个转移性黑色素瘤。通过免疫组织化学评估p27和Jab1的表达。使用2和Fisher精确检验分析p27,Jab1和临床病理参数之间的关联。非参数皮尔逊秩相关用于评估p27和Jab1表达之间的关系。 p27在15例(88%)的痣,18例(95%)的增生性痣,11例(50%)的黑色素瘤中表达,仅在四例(13%)的转移性黑色素瘤中表达(PPr = -0.166)。原发性和转移性黑色素瘤病例中低水平的p27可能解释了此类病变的高增殖率。同样,Jab1在转移性黑素瘤中的相对高表达与低水平的p27相关,表明Jab1可能参与了转移性黑素瘤细胞的存活和增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号